Psychiatry News

The FDA has granted fast-track designation to a proprietary, scalable, allogeneic, investigational cellular therapy in development to address symptoms of mild Alzheimer’s disease, according to the manufacturer.

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.

The FDA recently approved injectable Kisunla to treat early-stage Alzheimer’s disease, joining Leqembi, which gained FDA approval in July 2023 for the same purpose.

Most physicians who are reluctant to treat addiction cited poor training and other institutional factors as major reasons for their hesitancy, a systematic review in JAMA Network Open showed.

Mushroom-containing nootropic gummies sold at gas stations and smoke shops in Virginia contained unlabeled psilocybin and psilocin, according to results of an investigation published in Morbidity and Mortality Weekly Report.

Individuals discharged from psychiatric inpatient care appeared vulnerable to premature death and suicidal behavior, according to a study published in JAMA Network Open.

Nightmares and hallucinations may occur at any stage of disease course in patients with systemic lupus erythematosus, according to recent findings.

U.S. News & World Report announced its 2024-2025 Best Hospitals rankings Tuesday.

Since the launch of the 988 Suicide & Crisis Lifeline in 2022, counselors have answered more than 10 million calls, texts and chats from people seeking help for suicidal thoughts and mental health crises, according to HHS officials.

Individuals with moderate to less severe treatment-resistant depression may benefit from treatment with ketamine instead of electroconvulsive therapy, according to research from JAMA Network Open.